GI Dynamics (ASX:GID) has a new global commercial head in Mark Twyman, who was appointed this week alongside Robert Solomon, who will be VP of finance.

Twyman will oversee international expansion of sales and marketing efforts for the Lexington, Mass.-based obesity and Type II diabetes treatment company’s flagship EndoBarrier device.